Increased activation of isolated intestinal lamina propria mononuclear cells in inflammatory bowel disease

S Schreiber1, R P MacDermott, A Raedler

  • 1Gastrointestinal Section, University of Pennsylvania School of Medicine, Philadelphia.

Gastroenterology
|October 1, 1991
PubMed

Insights

Lymphocyte activation is heightened in inflammatory bowel disease (IBD), affecting all major immune cell types in the gut. This study developed a method to accurately measure this activation, revealing its role in IBD

Area of Science:

  • Immunology
  • Gastroenterology

Background:

  • Normal human lamina propria lymphocytes exhibit heightened activation compared to peripheral blood, indicated by cell-surface activation antigen expression and immunoglobulin secretion.
  • Inflammatory bowel disease (IBD) involves significant immunological alterations in the intestinal mucosa.

Purpose of the Study:

  • To evaluate cell-surface expression of activation-associated antigens in colonic lamina propria mononuclear cell subpopulations in IBD.
  • To develop and validate a method for accurate flow-cytometric analysis of intestinal lymphocytes, addressing autofluorescence.

Main Methods:

  • Developed a computer-assisted method to subtract autofluorescence from flow cytometry data of intestinal lamina propria mononuclear cells.
  • Utilized fluorescence-activated cell sorting with autofluorescence subtraction for single-cell analysis.
  • Quantified expression of lymphocyte activation antigens (interleukin-2 receptor, transferrin receptor, 4F2) on B cells, T cells, CD4+ T cells, and CD8+ T cells.

Main Results:

  • A novel method effectively removed autofluorescence, enhancing sensitivity and specificity in flow-cytometric analyses of intestinal lamina propria mononuclear cells.
  • Significantly increased expression of lymphocyte activation antigens was observed on all investigated lymphocyte subpopulations (B cells, T cells, CD4+ T cells, CD8+ T cells) in both Crohn's disease and ulcerative colitis.
  • 5-aminosalicylic acid demonstrated a dose-dependent inhibition of activation antigen expression on mitogen-activated peripheral blood lymphocytes.

Conclusions:

  • Markedly increased intestinal lymphocyte activation is a key immunological feature across all studied lymphocyte subpopulations in IBD.
  • Lymphocyte activation likely contributes to the chronicity and perpetuation of IBD.
  • 5-aminosalicylic acid may exert therapeutic effects through the inhibition of lymphocyte activation.

Related Concept Videos

Renewal of Intestinal Stem Cells01:23

Renewal of Intestinal Stem Cells

The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
2.7K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.5K
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.6K
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows...
42
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal...
34
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
35